Partnering to Enhance Emerging Adults' Response to Programs

Part of paid clinical trials in Dallas, Texas.

Sponsor
UConn Health
Study ID
NCT06115252
Status
Recruiting

Conditions

  • Alcohol Use, Unspecified

Eligibility Criteria

Sex
ALL
Age
18 Years - 19 Years
Healthy Volunteers
Accepted

Interventions

  • Motivational Interviewing (MI) — BEHAVIORAL
    Motivational interviewing with peer dyads starts with an open-ended exploration of the dyad's hazardous drinking behavior via personal stories about alcohol use. It includes a values clarification task and age-matched norms along with personalized feedback regarding the dyad's alcohol use. The goal of the session is to engage the dyad in a thoughtful conversation about drinking and the implications it may have on their lives, with an eye to bolstering and supporting inherent drive for behavior change.

Study Details

The goal of this clinical trial (CT) is to learn more about emerging adults' and their peers. Here, we will see how co-participating with a peer in health program might impact brain and behavior change over time. Eligible youth will be invited to come in for a "Participation Day," during which they and a peer will independently complete questionnaires. With a peer, they will then complete a short health program, and undergo a brain scan (fMRI) while completing activities. Our study team will reach out to each participant individually again 3, 6, and 12 months later to learn about health behaviors over time.

Key Dates

Start date
Oct 10, 2025
Status verified
Feb 2026
Primary completion
Mar 31, 2028
Completion
Mar 31, 2028

Study Design

Enrollment
248 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Motivational Interviewing (MI)

Primary Outcome Measure

Blood oxygen level dependent (BOLD) response synchrony [ Time Frame: Baseline ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Texas DallasDallasTexas75235
Cameron Sullins, BS
972-883-3726
Francesca Filbey, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Dallas, TX

Related Studies